GS
65
16
PM
49
8
NTRS
35
10
EQIX
59
2
PX
56
3
FIS
43
5
WM
53
2
D
32
10
CMS
57
2
LMT
29
-5
DTE
49
16
SHW
42
5
MTB
38
4
DGX
28
4
KSS
36
2
PHM
44
4
GOOG
77
14
CI
35
2
TROW
37
8
SNA
56
3
GS
65
16
PM
49
8
NTRS
35
10
EQIX
59
2
PX
56
3
FIS
43
5
WM
53
2
D
32
10
CMS
57
2
LMT
29
-5
DTE
49
16
SHW
42
5
MTB
38
4
DGX
28
4
KSS
36
2
PHM
44
4
GOOG
77
14
CI
35
2
TROW
37
8
SNA
56
3
Financhill
Back

Lexicon Pharmaceuticals Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
27

LXRX
Lexicon Pharmaceuticals

Last Price:
$0.70
Seasonality Move:
5.4%
Buy
51

HALO
Halozyme Therapeutics

Last Price:
$46.95
Seasonality Move:
7.09%
Sell
27
Lexicon Pharmaceuticals (LXRX) is a Sell

Is Lexicon Pharmaceuticals a Buy, Sell or Hold?

  • The current Lexicon Pharmaceuticals [LXRX] share price is $0.71. The Score for LXRX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • LXRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Halozyme Therapeutics (HALO) is a Buy

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $46.93. The Score for HALO is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • HALO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

LXRX Stock Price Chart

What is Lexicon Pharmaceuticals's stock price today?

  • The Lexicon Pharmaceuticals share price today is $0.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LXRX is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $46.93
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

LXRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 37.03 Sell
Chaikin Money Flow: -3708513 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.7 - 0.86) Sell
Bollinger Bands (100): (1.01 - 1.87) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.11 Sell
Relative Strength Index (14 RSI): 40.79 Sell
Chaikin Money Flow: -4132103 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.97 - 48.99) Sell
Bollinger Bands (100): (49.23 - 60.41) Sell

LXRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.77 Sell
20-day SMA: 0.76 Sell
50-day SMA: 1.2 Sell
200-day SMA: 1.68 Sell
8-day EMA: 0.74 Sell
20-day EMA: 0.81 Sell
50-day EMA: 1.07 Sell
200-day EMA: 1.54 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.62 Sell
20-day SMA: 48.12 Sell
50-day SMA: 51 Sell
200-day SMA: 50.14 Sell
8-day EMA: 47.61 Sell
20-day EMA: 48.45 Sell
50-day EMA: 50.73 Sell
200-day EMA: 50.06 Sell

Lexicon Pharmaceuticals Earnings Growth & LXRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.20 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

Lexicon Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):